GLP-1s, SGLT2s, and Diabetes Barbie at ENDO 2025
- Author
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
- Published
- Mon 21 Jul 2025
- Episode Link
- https://audioboom.com/posts/8751769
Welcome back to Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives!
In this episode of Diabetes Dialogue, cohosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and co-director of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, recapped highlights from the 2025 Endocrine Society annual meeting. They spotlighted advances, controversies, and ongoing unmet needs in type 1 diabetes care.
00:00:00 Intro
00:00:40 GLP-1 RAs in type 1 diabetes
00:05:50 Tirzepatide in type 1 diabetes
00:08:32 Cardioprotective therapies in type 1 diabetes
00:12:17 Type 1 diabetes Barbie and public education
In this episode of Diabetes Dialogue, cohosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and co-director of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, recapped highlights from the 2025 Endocrine Society annual meeting. They spotlighted advances, controversies, and ongoing unmet needs in type 1 diabetes care.
00:00:00 Intro
00:00:40 GLP-1 RAs in type 1 diabetes
00:05:50 Tirzepatide in type 1 diabetes
00:08:32 Cardioprotective therapies in type 1 diabetes
00:12:17 Type 1 diabetes Barbie and public education
